fda 503b bulks list bpc-157 Is Legal in 2026? Compounding Status Explained FDA Moves to Exclude Semaglutide,
FDA Moves to Exclude Semaglutide, Tizerpatide, and Liraglutide from 503B Bulk Substances List Lengea The FDA just dropped a 68 page PDF on if BPC 157 should be legal or not to compound. Their initial recommendation: DO NOT add BPC 157 to the 503A Bulks List. They're meeting this FDA reviewers urge 'no' on BPC 157, TB 500, MOTS c ahead of July 2026 compounding vote PeptideKnow Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law fda category 2 bulk drug substances list bpc 157 FDA Peptide Reclassification 2026: What It Means
Pay in 4 interest-free payments of $7.10 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




